INS and metabolic syndrome: The following variables had values of standardized difference >10%: age, nephropathy, eye diseases, dyslipidemia, insulin, meglitinide, acarbose, rosiglitazone, pioglitazone, statin and fibrate, suggesting potential risk of confounding from these variables.